Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure used to replace damaged heart valves, offering patients an alternative to open heart surgery.
賱賳丿賳 鈥� 亘丿兀 丕賱兀卮禺丕氐 丨賵賱 丕賱毓丕賱賲 賮賷 丕賱丕賳禺乇丕胤 賮賷 丕賱兀賳卮胤丞 丕賱禺丕乇噩賷丞 亘毓丿 賯囟丕亍 兀睾賱亘 賮氐賱 丕賱卮鬲丕亍 丿丕禺賱 賲賳丕夭賱賴賲 賲氐丨賵亘賸丕 乇亘賲丕 亘賳卮丕胤 亘丿賳賷 兀賯賱 賲賯丕乇賳丞賸 亘丕賱賲賵丕爻賲 丕賱兀賰孬乇 丕毓鬲丿丕賱丕賸. 賮賮賷 賲賳丕禺丕鬲 兀禺乇賶貙 賯丿 賷亘丿兀 丕賱兀卮禺丕氐 賮賷 賯囟丕亍 賵賯鬲 兀賯賱 賳卮丕胤賸丕 丿丕禺賱 賲賳丕夭賱賴賲.鬲賯丿賲 噩賵卮賷丕 賵丕賲賱貙 丿賰鬲賵乇丞 賮賷 丕賱胤亘貙 賵丨丕氐賱丞 毓賱賶 丕賱丿賰鬲賵乇丕賴貙 賵胤亘賷亘丞 丕賱賯賱亘 賮賷 賲丕賷賵 賰賱賷賳賰 賴賷賱孬賰賷乇 賮賷 賱賳丿賳貙 禺賲爻 賳氐丕卅丨 賱丨賲丕賷丞 賯賱亘賰 毓賳丿 丕賱亘丿亍 亘丕賱丕賳胤賱丕賯 亘毓丿 賮鬲乇丞 賲賳 丕賱禺賲賵賱.
A research team reveals the promising antihypertensive effects of egg white hydrolysates (EWH) and ovotransferrin-depleted egg white hydrolysates (OD-EWH) in spontaneously hypertensive rats (SHRs), suggesting that these natural ingredients could be effective alternatives to traditional pharmaceuticals for managing hypertension.
The ongoing shortage of donor hearts for children who need them stems from multiple causes, including a lack of donor awareness, organ allocation issues, and not enough organs that are of sufficient quality to transplant. Currently, new hearts for kids are still hard to find, and they are even scarcer for babies. Infants are particularly hard to match with a heart.
A team led by Children鈥檚 Hospital Los Angeles has become the first in the world to demonstrate the possibility of using genetically engineered pig hearts as a potential 鈥渂ridge鈥� to heart transplant for critically ill babies. The groundbreaking preclinical research could lead to a lifesaving alternative for supporting critically ill babies waiting for a new heart鈥攑articularly those with single-ventricle heart disease, most of whom currently die while waiting for a transplant.
The Society of Thoracic Surgeons (STS) today announced the launch of its latest surgical risk calculator designed for patients undergoing ascending aorta and aortic root surgery, with or without concomitant aortic valve replacement (AVR).
New research has shown that hypertensive individuals who maintain optimal control of several key health risk factors鈥攕uch as blood pressure, cholesterol, and lifestyle behaviors鈥攃an significantly reduce their risk of dying prematurely. The study found that with each additional risk factor brought under control, the risk of death from cancer, cardiovascular disease, and other causes dropped substantially. Most importantly, those who achieved high levels of joint risk factor control had no greater risk of early death than people without hypertension. This suggests that a comprehensive, multi-pronged approach to managing hypertension could effectively eliminate the excess mortality risk associated with the condition.
Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to encourage tissue repair and promotes survival of heart muscle cells after a heart attack.
Mount Sinai-led research can transform how hospitals triage, risk-stratify, and counsel patients to save lives
Cardiology faculty practice is the only heart center in New York to receive the Pinnacle of Excellence Award
The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by researchers at UTHealth Houston, potentially paving the way for innovative treatments that align with the natural circadian rhythm.
Field Medical Inc., a leader in cardiac pulsed field ablation (PFA) technology, announced today its FieldForce鈩� Ablation System will be featured in eight scientific presentations at the 46th annual Heart Rhythm Society (HRS) meeting, April 24鈥�27, in San Diego, Calif.
Join 300+ mini-medics as they explore the exciting world of health care with dozens of activities designed to help shape the next generation of lifesavers.
Mount Sinai-led research can transform how hospitals triage, risk-stratify, and counsel patients to save lives
Children鈥檚 Hospital Los Angeles experts are set to speak at nearly 80 sessions and poster presentations at the 2025 Pediatric Academic Societies (PAS) meeting April 24-28 in Honolulu.
Every eight minutes, someone joins the transplant waiting list in the United States, and just one organ donor can save up to eight lives. Penn State Health experts tell how registering as an organ donor can give others a second chance at life.
Researchers from Children鈥檚 Hospital Los Angeles and the USC Viterbi School of Engineering have received key funding to support their work on a novel device: an artificial right atrium for patients with a Fontan circulation. The investigators鈥擟ynthia Herrington, MD, and Andrew Cheng, MD, of CHLA, and Niema Pahlevan, PhD, of USC鈥攔eceived the USC Nemirovsky Engineering and Medicine Opportunity (NEMO) Prize.
FDA Approves WiSE庐 System, World's First and Only Leadless Left Ventricular Endocardial Pacing (LVEP) Device for CRT
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 蜜桃传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right